Charles Schwab’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,043
| Closed | -$38.1K | – | 3497 |
|
|
2024
Q3 | $38.1K | Hold |
3,043
| – | – | ﹤0.01% | 3441 |
|
|
2024
Q2 | $44.4K | Sell |
3,043
-11,237
| -79% | -$164K | ﹤0.01% | 3520 |
|
|
2024
Q1 | $320K | Hold |
14,280
| – | – | ﹤0.01% | 3162 |
|
|
2023
Q4 | $270K | Hold |
14,280
| – | – | ﹤0.01% | 3234 |
|
|
2023
Q3 | $244K | Hold |
14,280
| – | – | ﹤0.01% | 3248 |
|
|
2023
Q2 | $428K | Buy |
14,280
+11,237
| +369% | +$337K | ﹤0.01% | 3124 |
|
|
2023
Q1 | $89K | Hold |
3,043
| – | – | ﹤0.01% | 3265 |
|
|
2022
Q4 | $60.1K | Hold |
3,043
| – | – | ﹤0.01% | 3325 |
|
|
2022
Q3 | $93K | Hold |
3,043
| – | – | ﹤0.01% | 3228 |
|
|
2022
Q2 | $70K | Sell |
3,043
-11,071
| -78% | -$255K | ﹤0.01% | 3333 |
|
|
2022
Q1 | $632K | Buy |
14,114
+2,763
| +24% | +$124K | ﹤0.01% | 3031 |
|
|
2021
Q4 | $438K | Hold |
11,351
| – | – | ﹤0.01% | 3187 |
|
|
2021
Q3 | $577K | Hold |
11,351
| – | – | ﹤0.01% | 3096 |
|
|
2021
Q2 | $988K | Buy |
11,351
+9,630
| +560% | +$838K | ﹤0.01% | 2937 |
|
|
2021
Q1 | $77K | Buy |
+1,721
| New | +$77K | ﹤0.01% | 3400 |
|